Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005251 220002059 null null Curative (C) 2013-06-12 2013-06-26 AML17 TRIAL null N 220027773 AML17 TRIAL
220005252 220002059 null 83.3 Curative (C) 2014-06-29 2014-06-29 Trial Unspecified 01 N 220027773 TRIAL
220005253 220002060 null 78.8 Curative (C) 2015-03-22 2015-03-27 AML17 TRIAL N N 220027776 AML17 TRIAL
220005254 220002061 1.74 0 Palliative (P) 2013-12-30 2014-01-04 CYTARABINE 02 N 220027779 CYTARABINE
220005255 220002061 null 0 null 2014-11-17 2014-11-17 CYTARABINE 02 N 220027779 CYTARABINE
220005256 220002062 1.67 72.5 Curative (C) 2013-03-20 2013-03-20 Trial Unspecified 1 null 220027785 TRIAL
220005257 220002063 1.64 null Disease modification (D) 2017-06-24 2017-06-24 LI-1 TRIAL Y N 220027786 TRIAL
220005258 220002064 1.81 97.1 Curative (C) 2013-01-28 2013-02-03 Trial Unspecified Y N 220027787 TRIAL
220005259 220002064 1.74 107 Palliative (P) 2013-05-11 2013-05-18 AML17 TRIAL 2 N 220027787 AML17 TRIAL
220005260 220002064 1.7 89.6 Palliative (P) null 2015-05-21 AML17 TRIAL N N 220027787 AML17 TRIAL
220005268 220002067 1.65 93.3 Curative (C) 2016-08-31 2016-08-31 CYTARABINE N N 220027810 CYTARABINE
220005269 220002067 1.63 70 Disease modification (D) 2014-11-18 2014-11-22 Cytarabine Low Dose 02 N 220027810 CYTARABINE
220005270 220015940 1.61 null Curative (C) null 2014-05-01 Cytarabine Low Dose N null 220027813 CYTARABINE
220005271 220002068 1.8 65.9 Palliative (P) 2017-09-21 2017-09-21 AML17 TRIAL N N 220027814 AML17 TRIAL
220005272 220002069 1.69 null null 2013-03-05 2013-03-05 Cytarabine Low Dose 99 N 220027816 CYTARABINE
220005273 220011106 1.86 null Palliative (P) null 2014-08-11 CYTARABINE null null 220027818 CYTARABINE
220005274 220011106 1.82 56.5 Curative (C) 2014-09-02 2014-09-03 AML17 TRIAL 1 N 220027818 AML17 TRIAL
220005275 220002070 1.53 55.5 Curative (C) 2017-01-27 2017-02-07 Trial Unspecified Y N 220027823 TRIAL
220005276 220011107 1.83 64 Curative (C) 2013-09-22 2013-09-22 AML17 TRIAL 2 N 220027825 AML17 TRIAL
220005277 220002071 1.64 73.8 Not known (9) 2017-07-14 2017-07-14 AML17 TRIAL Y N 220027826 AML17 TRIAL
220005278 220002071 1.62 86 Curative (C) 2014-01-22 2014-01-22 AML17 TRIAL N N 220027826 AML17 TRIAL
220005279 220002071 null 0 Curative (C) 2013-04-11 2013-04-11 Cytarabine Low Dose N N 220027826 CYTARABINE
220005280 220002071 1.71 73.899 Curative (C) 2016-05-17 2016-05-23 AML17 TRIAL N N 220027826 AML17 TRIAL
220005281 220002071 1.63 null Curative (C) 2015-06-15 2015-06-16 LI-1 TRIAL 01 N 220027826 TRIAL
220005282 220002071 null 97.05 null 2017-03-10 2017-03-19 AML17 TRIAL N N 220027826 AML17 TRIAL
220005283 220002072 1.62 69 Adjuvant (A) 2014-03-14 2014-03-19 AML17 TRIAL 01 N 220027837 AML17 TRIAL
220005284 220002072 null null Curative (C) 2017-03-21 2017-03-21 Trial Unspecified Y null 220027837 TRIAL
220005285 220002073 0 0 Curative (C) 2015-06-24 2015-06-24 Cytarabine Low Dose 2 N 220027842 CYTARABINE
220005286 220002073 1.55 106.1 null 2014-05-06 2014-05-08 CYTARABINE N N 220027842 CYTARABINE
220005287 220002074 1.61 52.8 Palliative (P) 2016-07-11 2016-07-12 Cytarabine Low Dose N N 220027845 CYTARABINE
220005288 220011111 1.68 104 Palliative (P) 2014-08-31 2014-08-31 Cytarabine Low Dose N N 220027849 CYTARABINE
220005289 220002075 1.8 null Curative (C) 2015-08-02 2015-08-03 Cytarabine Low Dose N N 220027851 CYTARABINE
220005290 220002075 1.68 98 null 2014-11-27 2014-11-28 Cytarabine Low Dose 02 N 220027851 CYTARABINE
220005291 220002075 1.82 null Palliative (P) null 2015-09-20 Cytarabine Intrathecal (any age) null null 220027851 CYTARABINE
220005292 220002076 null 83 Disease modification (D) 2016-04-22 2016-04-25 Trial Unspecified Y N 220027857 TRIAL
220005293 220002077 1.56 null Disease modification (D) 2016-10-27 2016-10-30 Trial Unspecified 1 null 220027860 TRIAL
220005294 220002077 0 80.1 Curative (C) 2015-12-02 2015-12-02 AML17 TRIAL Y N 220027860 AML17 TRIAL
220005295 220002077 1.68 51 Disease modification (D) 2017-06-19 2017-06-21 Trial Unspecified Y null 220027860 TRIAL
220005296 220002078 1.76 77.3 Curative (C) 2017-09-04 2017-09-04 Trial Unspecified N N 220027864 TRIAL
220005297 220002078 1.75 null null 2013-04-05 2013-04-05 CYTARABINE Y N 220027864 CYTARABINE
220005298 220002078 1.63 null Palliative (P) 2015-07-18 2015-08-09 Cytarabine low (10to20mg/m2) IV/SC N N 220027864 CYTARABINE
220005299 220002078 1.83 null Not known (9) 2013-01-04 2013-01-07 AML17 TRIAL 02 N 220027864 AML17 TRIAL
220005300 220002078 1.77 67.3 null 2015-07-09 2015-07-10 CYTARABINE 02 N 220027864 CYTARABINE
220005301 220002078 null 71 Palliative (P) 2015-06-21 2015-06-21 Cytarabine Low Dose N N 220027864 CYTARABINE
220005302 220021709 1.57 64.5 Palliative (P) 2016-03-31 2016-04-02 Cytarabine Low Dose 02 N 220027871 CYTARABINE
220005303 220021709 1.66 76.2 Not known (9) 2016-07-07 2016-07-08 AML17 TRIAL 1 N 220027871 AML17 TRIAL
220005304 220002079 1.84 null Curative (C) null 2017-04-26 AML17 TRIAL N N 220027875 AML17 TRIAL
220005305 220011115 null null Palliative (P) 2013-10-15 2013-10-15 CYTARABINE N N 220027880 CYTARABINE
220005306 220011115 1.71 null Curative (C) 2013-09-05 2013-10-10 AML17 TRIAL Y N 220027880 AML17 TRIAL
220005307 220002080 1.57 109.1 Palliative (P) 2014-04-20 2014-04-20 Cytarabine Low Dose null null 220027886 CYTARABINE